The IPO Buzz: Thyroid-Focused Septerna Sets Terms & Launches $175 Million IPO
Septerna Inc. (SEPN Proposed), a Phase 1 biotech focused on developing an oral drug to treat hypoparathyroidism, a rare endocrine disease, unveiled the terms for its $175 million IPO early today – Monday, Oct. 21, 2024. Septerna is offering 10.94 million shares at a price range of $15.00 to $17.00 to raise $175.0 million, if priced at the $16.00 mid-point of its range. The market cap would be ..
Read more October 21, 2024IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| Aldel Financial II | ALDFU | 20.0 | $ 200.0 mil | 10/22/2024 Priced | S/O | S/O |
| HUHUTECH International Group | HUHU | 1.1 | $ 4.2 mil | 10/22/2024 Priced | S/O | S/O |
| Linkers Industries | LNKS | 2.2 | $ 11.0 mil | 10/22/2024 Tuesday | S/O | S/O |
Last 100 IPOs - October 21, 2024
| Number of IPOs priced : | 100 |
| Number Up: | 46 |
| Number Down: | 51 |
| Number Unchanged: | 3 |
| Percentage Change From Issue Price: | 10.80% |
| Percentage Change for The Nasdaq Composite | 13.88% |
2024 IPO Scorecard - October 21, 2024
| Number of IPOs priced (Excluding 37 units) : | 143 |
| Number Up: | 56 |
| Number Down: | 84 |
| Number Unchanged: | 3 |
| Total Return From Issue Price: | 9.00% |
| The Nasdaq Composite Index YTD % Change | 24.31% |